Author:
Mizokami Masashi,Yokosuka Osamu,Takehara Tetsuo,Sakamoto Naoya,Korenaga Masaaki,Mochizuki Hitoshi,Nakane Kunio,Enomoto Hirayuki,Ikeda Fusao,Yanase Mikio,Toyoda Hidenori,Genda Takuya,Umemura Takeji,Yatsuhashi Hiroshi,Ide Tatsuya,Toda Nobuo,Nirei Kazushige,Ueno Yoshiyuki,Nishigaki Yoichi,Betular Juan,Gao Bing,Ishizaki Akinobu,Omote Masa,Mo Hongmei,Garrison Kim,Pang Phillip S,Knox Steven J,Symonds William T,McHutchison John G,Izumi Namiki,Omata Masao
Reference15 articles.
1. Changing trends in hepatitis C infection over the past 50 years in Japan;Chung;Intervirology,2010
2. JSH Guidelines for the Management of Hepatitis C Virus Infection: a 2014 update for genotype 1;Hepatol Res,2014
3. Simeprevir with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial;Hayashi;J Hepatol,2014
4. Once-daily simeprevir with peginterferon and ribavirin for treatment-experienced HCV genotype 1-infected patients in Japan: the CONCERTO-2 and CONCERTO-3 studies;Izumi;J Gastroenterol,2014
5. Simeprevir (TMC435) once daily with peginterferon-α-2b and ribavirin in patients with genotype 1 hepatitis C virus infection: The CONCERTO-4 study;Kumada;Hepatol Res,2014
Cited by
325 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献